Internal medicine Cardiology

The International Symposium on Triglyceride/Neutral Lipid and Rare Diseases will be held at the Kyoto International Conference Center on October 21 and 22, 2023. The symposium is organized by the International Symposium on Triglyceride/Neutral Lipid and Rare Diseases Conference Committee, which is led by Dr. Ken-ichi Hirano (Graduate School of Medicine, Osaka University) and the Japan Intractable Diseases (Nanbyo) Research Foundation.

Researchers from Osaka University found that patients with persistently high levels of urinary albumin excretion in the long term are at high risk of new-onset heart failure. Preventive treatment associated with the lowering of urinary albumin excretion levels in these patients could reduce the risk of later heart failure or mortality.

New research found that periodontitis, a common gum infection known to worsen other systemic diseases, could also be linked to atrial fibrosis — potentially clarifying its previously unknown connection with atrial fibrillation.

Researchers from Osaka University found that dietary supplementation with tricaprin results in coronary artery plaque regression and resolution of symptoms in patients with triglyceride deposit cardiomyovasculopathy, a treatment-resistant form of coronary artery disease. These findings represent a conceptually novel treatment for coronary atherosclerosis that paves the way toward establishing a multi-faceted approach to caring for patients with this condition.

A study by Osaka University has shown that the prevalence of non-communicable diseases, which included hypertension, hyperlipidemia, diabetes, and mental disorders, increased after the Fukushima disaster and the COVID-19 outbreak. These findings emphasize the importance of improving post-disaster health promotion strategies and recommendations.